secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tonix Pharmaceuticals Holding Corp. (TNXP)
CIK:        0001430306
Form:       8-K
Filed at:   2025-02-04T23:59:59+00:00
Accession:  0001999371-25-001136
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tonix promotes Siobhan Fogarty to Chief Technical Officer; PDUFA date Aug 15, 2025
--------------------------------------------------------------------------------

- Siobhan Fogarty appointed CTO effective February 3, 2025; annual salary of €385,000.
- Fogarty previously served as EVP Product Development since February 2021 and joined Tonix in 2016.
- FDA PDUFA goal date for TNX-102 SL (fibromyalgia) remains August 15, 2025; NDA submitted.
- Company preparing for potential launch of TNX-102 SL for management of fibromyalgia.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1430306/000199937125001136/0001999371-25-001136-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1430306/000199937125001136/tnxp_8k-020425.htm
  HTML page:      https://secwatch.observer/filing/0001999371-25-001136

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer